July 4, 2022
VLP Therapeutics Japan and Shionogi became the first batch of drug makers to be selected for a vaccine development funding program by the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA). The selection of...read more